<!DOCTYPE html>
<html lang="en">
<head>

<title>NezNet.Site</title>

<link rel="icon" type="image/png" href="../../../images/universal/logo.png" />

<meta name="viewport" content="width=device-width, initial-scale=1">
<meta charset="utf-8">

<script src="/NezNet.Site/libraries/include-html.js"></script>

<!-- Imports stylesheet -->
<link rel="stylesheet" href="../../../style.css">
</head>

<body>
<!-- Please don't remove the next 2 lines! -->
<div id="top"></div>
<div id="skip"><a href="#content">Skip to content</a></div>

<div id="container">
<div id="sidebar">
<div id="sidebar-content">
<!-- Profile picture image -->
<div class="icon"><img src="../../../images/universal/pfp.png" alt="Profile picture" /></div>
<div include-html="../../../main-menu/site-name.html"></div>

<!-- Navigation menu  -->
<nav id="main-menu">
<ul>
    <div include-html="../../../main-menu/links.html"></div>
</ul>
</nav>
    <div include-html="../../../main-menu/site-message.html"></div>
</div>
</div>

<!-- Content area -->
<main id="content">
<!-- Section tags must be used for blocks -->
<section class="full">
<h1><b>Masculinizing GAHT Information</b></h1>
<p>Masculinizing hormone therapy (also known as testosterone-based GAHT) is typically undertaken by transmasculine or non-binary people aiming to appear and feel more masculine, it typically involves the administration of a form of testosterone either though injection, patches or gels <A href="#1">[1]</A>.</p>
</section>

<section class="full">
<h1><b>Effects</b></h1>
<p>Keep in mind that effect strength and onset can vary greatly between individuals, consider this table as an approximate guide only.</p>
<table>
  <tr>
    <th>Effect</th>
    <th>Expected Onset</th>
    <th>Expected Maximum Onset</th>
  </tr>
  <tr>
    <td>Skin oiliness/acne</td>
    <td>1–6 months</td>
    <td>1–2 years</td>
  </tr>
  <tr>
    <td>Facial/body hair growth</td>
    <td>6-12 months</td>
    <td>>5 years</td>
  </tr>
  <tr>
    <td>Scalp hair loss</td>
    <td>6-12 months*</td>
    <td>>5 years</td>
  </tr>
  <tr>
    <td>Increased muscle mass/strength</td>
    <td>6–12 months</td>
    <td>2–5 years**</td>
  </tr>
  <tr>
    <td>Fat redistribution</td>
    <td>1–6 months</td>
    <td>2–5 years</td>
  </tr>
  <tr>
    <td>Cessation of periods</td>
    <td>1–6 months</td>
    <td>1-2 years</td>
  </tr>
  <tr>
    <td>Clitoral enlargement</td>
    <td>1–6 months</td>
    <td>1–2 years</td>
  </tr>
  <tr>
    <td>Vaginal atrophy</td>
    <td>1–6 months</td>
    <td>1–2 years</td>
  </tr>
  <tr>
    <td>Deepened voice</td>
    <td>1-6 months</td>
    <td>1–2 years</td>
  </tr>
  <tr>
    <td>Increased sexual desire <A href="#1">[1]</A></td>
    <td>Variable</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td colspan="3">*Very dependent on age and genetics, effect may be small <A href="#2">[2]</A>.</td>
  </tr>
  <tr>
    <td colspan="3">**Significantly dependent on amount of exercise <A href="#2">[2]</A>.</td>
  </tr>
</table>
<p>Table adapted from Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 <A href="#3">[3]</A>.</p>
<p><b>Permanent Effects</b></p>
<ul>
    <li>Voice deepening (this can start with a scratchy feeling in the throat).</li>
    <li>Increased body hair growth (generally on the chest, back, arms).</li>
    <li>Increased facial hair growth (the amount varies between individuals).</li>
    <li>Hair loss at temples, possibly becoming bald with time depending on your age and family history.</li>
    <li>Genital changes:
    <ul>
        <li>Clitoral enlargement (possibly up to 1-3cm), this can feel uncomfortable, even painful initially.</li>
        <li>Vaginal dryness, can be relieved with estrogen cream and similar medicines. Additionally discomfort can be minimized with use of extra lubrication during vaginal sex.</li>
    </ul></li>
</ul>
<p><b>Likely Reversible Effects</b></p>
<ul>
    <li>Acne/oily skin (acne is usually worst in the first year but then slowly improves).</li>
    <li>Increased muscle mass and upper body strength.</li>
    <li>Redistribution of body fat (less fat on hips, bum and thighs, more around abdomen).</li>
    <li>Increased libido, can lead to sex and orgasms feeling different.</li>
    <li>Cessation of periods (certain medication can be taken to stop this earlier).</li>
</ul>
<p>Lists adapted from Guidelines for gender affirming healthcare for gender diverse and transgender children, young people and adults in Aotearoa New Zealand <A href="#4">[4]</A>.</p>
<p><b>Effects On Fertility</b></p>
<p>The long term effects of testosterone-based GAHT on fertility are currently unclear. It is known that testosterone prevents the ovaries from working, but it is unknown as whether this will be reversible or not. Therefor in order to carry a pregnancy testosterone must be halted, as it is harmful to the developing fetus (currently the exact length of time it needs to be stopped before a pregnancy is unknown and a discussion with a doctor before attempting a pregnancy is recommended).</p>
<p>After stopping testosterone fertility could return, allowing for an unassisted pregnancy. However, it may not return and pregnancy may require fertility assistance, usually involving egg harvesting, as testosterone rarely affects egg quality <A href="#4">[4]</A>.</p>
<p><b>Testosterone Is NOT A Contraceptive</b></p>
<p>Vaginal sex may still result in pregnancy, even if periods have stopped. Contraceptives should be used to avoid unexpected pregnancy <A href="#5">[5]</A>.</p>
</section>

<section class="full">
<h1><b>Citations</b></h1>
<ul>
    <A name="1"><li>[1]</A> Radix A. 2019. Hormone Therapy for Transgender Adults. Urologic Clinics of North America. 46(4):467–473. doi:<a href="https://doi.org/10.1016/j.ucl.2019.07.001">https://doi.org/10.1016/j.ucl.2019.07.001</a>.</li>
    <A name="2"><li>[2]</A> Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, et al. 2012. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism. 13(4):165–232. doi:<a href="https://doi.org/10.1080/15532739.2011.700873">https://doi.org/10.1080/15532739.2011.700873</a>. <a href="https://www.tandfonline.com/doi/abs/10.1080/15532739.2011.700873">https://www.tandfonline.com/doi/abs/10.1080/15532739.2011.700873</a>.</li>
    <A name="3"><li>[3]</A> Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, et al. 2022. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health. 23(S1):S1–S259. doi:<a href="https://doi.org/10.1080/26895269.2022.2100644">https://doi.org/10.1080/26895269.2022.2100644</a>. <a href="https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644">https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644</a>.</li>
    <A name="4"><li>[4]</A> Oliphant J, Veale J, Macdonald J, Carroll R, Johnson R, Harte M, Stephenson C, Bullock J. 2018. Guidelines for gender affirming healthcare for gender diverse and transgender children, young people and adults in Aotearoa New Zealand. researchcommonswaikatoacnz. <a href="https://hdl.handle.net/10289/12160">https://hdl.handle.net/10289/12160</a>.</li>
    <A name="5"><li>[5]</A> Feil K, Reiser E, Braun A-S, Böttcher B, Toth B. 2023. Fertility, Contraception, and Fertility Preservation in Trans Individuals. Deutsches Arzteblatt International. 120(14):243–250. doi:<a href="https://doi.org/10.3238/arztebl.m2023.0026">https://doi.org/10.3238/arztebl.m2023.0026</a>. <a href="https://pubmed.ncbi.nlm.nih.gov/36794399/">https://pubmed.ncbi.nlm.nih.gov/36794399/</a>.</li>
</ul>
</section>

<footer id="main-footer">
<p>Updated 12/8/2024</p>
<div include-html="../../../footer/links.html"></div>
</footer>
</main>
</div>

<script>
includeHTML();
</script>
</body>
</html>
